AXTG yields 2000000.00% · JNJ yields 2.13%● Live data
📍 AXTG pulled ahead of the other in Year 1
Combined, AXTG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AXTG + JNJ for your $10,000?
Axis Technologies Group, Inc., through its subsidiary, Axis Technologies, Inc., designs, manufactures, and markets a range of daylight harvesting fluorescent lighting ballasts for the commercial lighting industry in North America. The company offers patented T8 Axis Daylight Harvesting Dimming Ballast, which are used to reduce the lighting energy costs. It also develops a line of dimming and daylight harvesting ballasts that would utilize 54 watt lamps; and a line of addressable and load shedding ballasts, which would allow communications between the fixtures installed in the building and the building management systems. The company focuses on marketing its products to commercial users of fluorescent lighting fixtures, including office buildings, wholesale and retail buildings, hospitals, schools, and government buildings. The company was formerly known as Axis Technologies, Inc. and changed its name to Axis Technologies Group, Inc. in September 2006. Axis Technologies Group, Inc. was founded in 1997 and is headquartered in Los Angeles, California.
Full AXTG Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.